Profile data is unavailable for this security.
About the company
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include HB-200 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial. HB-700 is in preclinical development for the treatment of KRAS mutated cancers, including lung, colorectal and pancreatic cancers. Its Hepatitis B (HBV) program, HB-400, and its Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in a partnership with Gilead Sciences, Inc.
- Revenue in USD (TTM)53.55m
- Net income in USD-47.52m
- Incorporated2017
- Employees151.00
- LocationHOOKIPA Pharma Inc350 Fifth Avenue, 72Nd Floor, Suite 7240NEW YORK 10118United StatesUSA
- Fax+1 (302) 655-5049
- Websitehttps://www.hookipapharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bright Green Corp | 0.00 | -11.46m | 45.13m | 5.00 | -- | 4.06 | -- | -- | -0.0631 | -0.0631 | 0.00 | 0.0584 | 0.00 | -- | -- | 0.00 | -56.05 | -- | -84.87 | -- | -- | -- | -- | -- | -- | -18,125.84 | 0.0289 | -- | -- | -- | 52.54 | -- | -- | -- |
| United-Guardian, Inc. | 11.57m | 2.75m | 48.01m | 25.00 | 17.45 | 4.30 | 16.81 | 4.15 | 0.5987 | 0.5987 | 2.52 | 2.43 | 0.926 | 3.17 | 6.40 | 462,790.80 | 22.02 | 29.84 | 25.94 | 34.39 | 48.64 | 55.31 | 23.78 | 28.79 | 5.99 | -- | 0.00 | 97.37 | -14.28 | -4.14 | 0.4616 | -9.92 | 17.19 | -19.73 |
| Lexaria Bioscience Corp | 411.01k | -4.85m | 49.64m | 5.00 | -- | 4.90 | -- | 120.79 | -0.4455 | -0.4455 | 0.0408 | 0.6403 | 0.0539 | -- | 2.16 | 82,202.00 | -63.85 | -95.67 | -65.93 | -96.58 | 98.83 | 76.98 | -1,185.15 | -1,612.76 | -- | -64.96 | 0.00 | -- | -11.43 | -12.19 | 8.31 | -- | -- | -- |
| Odonate Inc | 0.00 | -102.07m | 50.02m | 137.00 | -- | 1,844.41 | -- | -- | -13.59 | -13.59 | 0.00 | 9.27 | 0.00 | -- | -- | 0.00 | -66.98 | -58.36 | -83.00 | -65.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | -- | -- |
| Ocuphire Pharma Inc | 19.01m | -11.30m | 51.59m | 14.00 | -- | 1.08 | -- | 2.71 | -0.4867 | -0.4867 | 0.8366 | 1.84 | 0.391 | -- | 4.52 | 1,357,929.00 | -23.24 | -58.31 | -25.89 | -65.94 | -- | -- | -59.44 | -137.92 | -- | -7.80 | 0.00 | -- | -52.20 | -- | -155.83 | -- | -- | -- |
| Immix Biopharma Inc | 0.00 | -18.21m | 54.41m | 14.00 | -- | 1.95 | -- | -- | -0.9263 | -0.9263 | 0.00 | 1.06 | 0.00 | -- | -- | 0.00 | -77.50 | -- | -90.46 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -87.44 | -- | -- | -- |
| Fortress Biotech Inc | 85.11m | -62.86m | 55.20m | 186.00 | -- | 2.07 | -- | 0.6486 | -6.65 | -6.65 | 7.96 | 1.19 | 0.3976 | 2.27 | 4.55 | 457,602.20 | -64.47 | -52.50 | -107.85 | -99.46 | 68.25 | 63.17 | -162.17 | -236.94 | 1.21 | -10.18 | 1.07 | -- | 11.58 | 25.75 | 27.42 | -- | -9.37 | -- |
| Rockwell Medical Inc | 86.62m | -8.42m | 57.45m | 237.00 | -- | 2.71 | -- | 0.6632 | -0.3584 | -0.3584 | 3.33 | 0.6984 | 1.90 | 13.28 | 10.12 | 365,485.20 | -18.47 | -46.29 | -27.53 | -65.38 | 10.59 | 4.66 | -9.72 | -36.51 | 1.38 | -3.54 | 0.331 | -- | 14.84 | 5.69 | 54.82 | -- | 76.21 | -- |
| Turnstone Biologics Corp | 0.00 | -74.92m | 58.05m | 82.00 | -- | 0.7256 | -- | -- | -3.53 | -3.53 | 0.00 | 3.46 | 0.00 | -- | -- | 0.00 | -80.25 | -- | -94.45 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -73.66 | -- | -78.05 | -- | -- | -- |
| Hookipa Pharma Inc | 53.55m | -47.52m | 59.57m | 151.00 | -- | 0.6943 | -- | 1.11 | -5.93 | -5.93 | 5.53 | 8.67 | 0.3467 | -- | 10.00 | 354,649.00 | -30.76 | -41.63 | -40.40 | -50.26 | -- | -- | -88.73 | -366.65 | -- | -- | 0.0108 | -- | 41.27 | 21.41 | -25.67 | -- | 14.11 | -- |
| Earth Science Tech Inc | 11.95m | 812.13k | 66.65m | 32.00 | 81.75 | 29.64 | 65.71 | 5.58 | 0.0026 | 0.0026 | 0.0386 | 0.0073 | 3.62 | 25.31 | -- | 373,550.90 | 24.58 | -37.98 | 42.57 | -- | 65.49 | 63.87 | 6.79 | -15.48 | 0.634 | 2.69 | 0.039 | -- | 24,526.37 | 73.03 | 322.25 | -- | -- | -- |
| Eagle Pharmaceuticals Inc | 257.55m | 11.95m | 69.87m | 134.00 | 5.91 | 0.2795 | 2.14 | 0.2713 | 0.911 | 0.911 | 19.59 | 19.25 | 0.6549 | 1.55 | 2.56 | 1,922,022.00 | 3.04 | 6.37 | 4.04 | 7.98 | 69.84 | 71.86 | 4.64 | 7.85 | 1.67 | 3.55 | 0.2178 | 0.00 | 84.56 | 5.99 | 513.14 | -8.42 | -49.05 | -- |
| CEL-SCI Corp | 0.00 | -29.95m | 73.12m | 43.00 | -- | 5.10 | -- | -- | -0.6304 | -0.6304 | 0.00 | 0.2645 | 0.00 | -- | -- | -- | -87.78 | -70.19 | -103.56 | -78.31 | -- | -- | -- | -15,434.15 | 1.18 | -39.26 | 0.4319 | -- | -- | -- | 13.99 | -- | 223.59 | -- |
| Journey Medical Corp | 80.00m | -4.16m | 75.67m | 58.00 | -- | 8.31 | -- | 0.9459 | -0.3095 | -0.3095 | 4.13 | 0.6498 | 0.985 | 2.27 | 4.28 | 1,379,276.00 | -5.12 | -- | -17.85 | -- | 66.22 | -- | -5.20 | -- | 0.9357 | 0.4049 | 0.5773 | -- | 7.48 | -- | 87.00 | -- | -- | -- |
